Advertisement

Breast Cancer Research and Treatment

, Volume 9, Issue 2, pp 111–121 | Cite as

Biological differences among MCF-7 human breast cancer cell lines from different laboratories

  • C. Kent Osborne
  • Kimberly Hobbs
  • Jeffrey M. Trent
Report

Summary

MCF-7 human breast cancer cells are used widely for studies of tumor biology and hormone mechanism of action. Conflicting results have often been obtained in studies reported from different laboratories. In this report several biological properties were studied in four MCF-7 cell lines obtained from different laboratories. MCF-7 (ATCC), MCF-7, MCF-7 (KO), and MCF-7 (S) demonstrated similar morphology in monolayer culture. Chromosome analysis revealed that three of the lines shared several structural chromosome alterations and marker chromsomes; however, MCF-7 (ATCC) was distinctly different with virtually no chromosomal alterations shared in common with the other lines. All four lines contained variable amounts of estrogen receptor (ER) and progesterone receptor (PgR). The growth rate of MCF-7 (ATCC) was 50% slower than that of the other lines, and, unlike the other three lines, cell proliferation was unaffected by estrogen or antiestrogen treatment despite the presence of receptors. Cloning efficiency of the four lines varied over a 10-fold range. Tumorigenicity in athymic nude mice also varied considerably among these lines. MCF-7 (ATCC) grew well in ovariectomized nude mice, while the other lines required estrogen supplementation. MCF-7 (S) and MCF-7 grew rapidly with estrogen supplementation; MCF-7 (KO) grew very slowly. Antiestrogen therapy inhibited growth of MCF-7, MCF-7 (S), and MCF-7 (KO) tumors, but it had no effect on MCF-7 (ATCC). These data demonstrate that MCF-7 lines from different laboratories may have unique biological properties, despite having a similar karyotype (MCF-7, MCF-7 (S), MCF-7 (KO)). The fundamental differences in karyotype and biological properties of the MCF-7 (ATCC), and the previously reported differences in DNA restriction fragment polymorphism analyses, demonstrate that this line is derived from an entirely different patient. Investigators should carefully document the source and identity of MCF-7 cells used in published experiments.

Key words

breast cancer cloning efficiency karyotype MCF-7 cells nude mice 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Soule H, Vazquez J, Long A, Albert S, Brennan M: A human cell line from a pleural effusion derived from a breast carcinoma. JNCI 51: 1409–1413, 1973PubMedGoogle Scholar
  2. 2.
    Lippman M, Osborne C, Knazek R, Young N: In vitro model systems for the study of hormone-dependent human breast cancer. N Engl J Med 296: 154–159, 1977PubMedGoogle Scholar
  3. 3.
    Osborne C, Hamilton B, Nover M: Receptor binding and processing of epidermal growth factor by human breast cancer cells. J Clin Endocrinol Metab 55: 86–93, 1982PubMedGoogle Scholar
  4. 4.
    Burke R, McGuire W: Nuclear thyroid hormone receptors in a human breast cancer cell line. Cancer Res 38: 3769–3773, 1978PubMedGoogle Scholar
  5. 5.
    Furlanetto R, DiCarlo J: Somatomedin-C receptors and growth effects in human breast cells maintained in longterm culture. Cancer Res 44: 2122–2128, 1984PubMedGoogle Scholar
  6. 6.
    Shafie S, Brooks S: Effect of prolactin on growth and the estrogen receptor level of human beast cancer cells (MCF-7). Cancer Res 37: 792–799, 1977PubMedGoogle Scholar
  7. 7.
    Shiu R: Processing of prolactin by human breast cancer cells in long term tissue culture. J Biol Chem 255: 4278–4281, 1980PubMedGoogle Scholar
  8. 8.
    Page M, Field J, Everett N, Green C: Serum regulation of the estrogen responsiveness of the human cancer cell line MCF-7. Cancer Res 43: 1244–1250, 1983PubMedGoogle Scholar
  9. 9.
    Lippman M, Bolan G, Huff K: The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Cancer Res 36: 4595–4601, 1976PubMedGoogle Scholar
  10. 10.
    Reiner G, Nardulli A, Norman M, Mangel W, Katzenellenbogen B: Relationships between cell proliferation, plasminogen activator activity, and progesterone receptor stimulation evaluated with a series of estrogens in MCF-7 breast cancer cells. Proc Am Assoc Cancer Res 25: 806, 1984Google Scholar
  11. 11.
    Edwards D, Murthy S, McGuire W: Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer. Cancer Res 40: 1722–1726, 1980PubMedGoogle Scholar
  12. 12.
    Briand P, Lykkesfeldt A: Effect of estrogen and antiestrogen on the human breast cancer cell line MCF-7 adapted to growth at low serum concentration. Cancer Res 44: 1114–1119, 1984PubMedGoogle Scholar
  13. 13.
    Shafie S: Estrogen and the growth of breast cancer: New evidence suggests indirect action. Science 209: 701–702, 1980PubMedGoogle Scholar
  14. 14.
    Huseby R, Maloney T, McGrath C: Evidence for a direct growth-stimulating effect of estradiol on human MCF-7 cellsin vivo. Cancer Res 44: 2654–2659, 1984PubMedGoogle Scholar
  15. 15.
    Soto A, Sonnenschein C: The role of estrogens on the proliferation of human breast tumor cells (MCF-7). J Steroid Biochem 23: 87–94, 1985PubMedGoogle Scholar
  16. 16.
    Reddel R, Murph L, Hall R, Sutherland R: Differential sensitivity of human breast cancer cell lines to the growthinhibitory effects of tamoxifen. Cancer Res 45: 1525–1531, 1985PubMedGoogle Scholar
  17. 17.
    Hand P, Nuti M, Colcher D, Schlom J: Definition of antigenic heterogeneity and modulation among human mammary carcinoma cell populations using monoclonal antibodies to tumor-associated antigens. Cancer Res 43: 728–735, 1983PubMedGoogle Scholar
  18. 18.
    Graham K, Richardson C, Minden M, Trent J, Buick R: Varying degrees of amplification of the N:ras oncogene in the human breast cancer cell line MCF-7. Cancer Res 45: 2201–2205, 1985PubMedGoogle Scholar
  19. 19.
    Graham K, Trent J, Osborne C, McGrath C, Minden M, Buick R: The use of restriction fragment polymorphisms to identify the cell line MCF-7. Breast Cancer Res Treat 8: 29–34, 1986PubMedGoogle Scholar
  20. 20.
    McGuire W, De La Garza M, Chamness G: Evaluation of estrogen receptor assays in human breast cancer tissue. Cancer Res 37: 637–639, 1977PubMedGoogle Scholar
  21. 21.
    Powell B, Garola R, Chamness G, McGuire W: Measurement of progesterone receptor in human breast cancer biopsies. Cancer Res 39: 1678–1682, 1979PubMedGoogle Scholar
  22. 22.
    Osborne C, Hobbs K, Clark G: Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45: 584–590, 1985PubMedGoogle Scholar
  23. 23.
    Trent J: Methods for chromosome banding analysis of human and experimental tumors in vitro. In: Gottesman M (ed) Molecular Genetics of Mammalian Cells. Academic Press, Orlando, 1986 (in press)Google Scholar
  24. 24.
    International system for human cytogenetic nomenclature (ISCN). Cytogenetics and Cell Genetics 21: 1–117, 1985Google Scholar
  25. 25.
    Winer B: Statistical Principles in Experimental Design. McGraw-Hill, New York, 1962Google Scholar
  26. 26.
    Osborne C, Boldt D, Estrada P: Human breast cancer cell cycle synchronization by estrogens and antiestrogens in culture. Cancer Res 44: 1433–1439, 1984PubMedGoogle Scholar
  27. 27.
    Whang-Peng J, Lee E, Kao-shan C, Seibert K, Lippman M: Cytogenetic studies of human breast cancer lines: MCF-7 and derived variant sublines. JNCI 71: 687–695, 1983PubMedGoogle Scholar
  28. 28.
    Berthois Y, Katzenellenbogen J, Katzenellenbogen B: Phenol red in tissue culture media is a weak estrogen: Implications concerning the study of estrogen-responsive cell in culture. Proc Natl Acad Sci USA 83: 2496–2500, 1986PubMedGoogle Scholar

Copyright information

© Martinus Nijhoff Publishers 1987

Authors and Affiliations

  • C. Kent Osborne
    • 1
  • Kimberly Hobbs
    • 1
  • Jeffrey M. Trent
    • 2
  1. 1.Department of Medicine Division of OncologyThe University of Texas Health Science Center at San AntonioSan AntonioUSA
  2. 2.Cancer CenterUniversity of Arizona Health Sciences CenterTucsonUSA

Personalised recommendations